George Karamanolis
Overview
Explore the profile of George Karamanolis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
863
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Voulgaris T, Alexopoulos T, Vlachogiannakos J, Kamberoglou D, Papatheodoridis G, Karamanolis G
Ann Gastroenterol
. 2025 Jan;
38(1):12-19.
PMID: 39802283
Background: Dysphagia and retrosternal chest pain are considered typical manifestations of major esophageal motility disorders (mEMD). High-resolution manometry (HRM) is the gold standard for mEMD diagnosis, while endoscopy and barium...
2.
Koureta E, Karatzas P, Kanellopoulos P, Papapanagiotou A, Lekakis V, Bamias G, et al.
J Physiol Biochem
. 2024 Nov;
PMID: 39560915
There are only scarce recent reports about the role of growth differentiation factor 15 (GDF-15) and some more data about interleukin-6 (IL-6) in inflammatory bowel diseases (IBD). We assessed GDF-15...
3.
Spinou M, Kyvelou E, Aggelopoulos G, Ziogas D, Panagaki A, Manti M, et al.
Ann Gastroenterol
. 2024 Sep;
37(5):499-508.
PMID: 39238791
Sedation and analgesia during gastrointestinal (GI) endoscopy increase procedural quality, contributing at the same time to greater patient satisfaction and willingness to undergo the procedure. Although sedation use has been...
4.
Koustenis K, Dovrolis N, Viazis N, Ioannou A, Bamias G, Karamanolis G, et al.
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791570
Introduction: Optimizing treatment with biological agents is an ideal goal for patients with ulcerative colitis (UC). Recent data suggest that mucosal inflammation patterns and serum cytokine profiles differ between patients...
5.
Koureta E, Karatzas P, Tampaki M, Voulgaris T, Laoudi E, Sakellariou S, et al.
Ann Gastroenterol
. 2024 Mar;
37(2):199-205.
PMID: 38481786
Background: The existing literature does not provide adequate guidance on the diagnosis and management of patients with nonspecific terminal ileitis, while data regarding the percentage of patients who ultimately develop...
6.
Ioannou A, Costanzini A, Giancola F, Cabanillas L, Lungaro L, Manza F, et al.
Ann Gastroenterol
. 2024 Jan;
37(1):22-30.
PMID: 38223240
Background: Chronic constipation (CC) is a severe symptom in Parkinson's disease (PD), with an unclear pathogenesis. Abnormalities of the enteric nervous system (ENS) and/or intestinal epithelial barrier (IEB) may be...
7.
Viazis N, Manolakis A, Vraka M, Mylonas I, Tsoukali E, Karamanolis G, et al.
Eur J Gastroenterol Hepatol
. 2024 Jan;
36(3):313-317.
PMID: 38179872
Background: Total proctocolectomy (TPC) followed by ileal pouch-anal anastomosis (IPAA) remains the only viable option whenever different treatment modalities fail in patients with ulcerative colitis (UC). Objective: Prospective cohort pre/post...
8.
Dovrolis N, Moschoviti A, Fessatou S, Karamanolis G, Kolios G, Gazouli M
Biomedicines
. 2023 Jul;
11(7).
PMID: 37509618
Background: Pediatric inflammatory bowel disease (IBD) is a chronic inflammatory intestinal disease that affects both children and adolescents. Symptoms can significantly affect a child's growth, development, and quality of life,...
9.
Palatianou M, Karamanolis G, Tsentidis C, Gourgiotis D, Papaconstantinou I, Vezakis A, et al.
Ann Gastroenterol
. 2023 Mar;
36(2):132-140.
PMID: 36864939
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract characterized in many patients by extraintestinal manifestations. One of the most common comorbidities seen in IBD patients...
10.
Voulgaris T, Lekakis V, Vlachogiannakos J, Kamberoglou D, Orfanidou A, Papatheodoridis G, et al.
Ann Gastroenterol
. 2023 Jan;
36(1):6-11.
PMID: 36593804
Background: Functional chest pain (FCP) is characterized by the presence of chest pain of presumed esophageal origin, but with a negative workup on routine investigations, including ruling out gastroesophageal reflux...